Chargement en cours...
Difluoromethylornithine attenuates isoproterenol-induced cardiac hypertrophy by regulating apoptosis, autophagy and the mitochondria-associated membranes pathway
Myocardial hypertrophy is an independent risk factor of cardiovascular diseases and is closely associated with the incidence of heart failure. In the present study, we hypothesized that difluoromethylornithine (DFMO) could attenuate cardiac hypertrophy through mitochondria-associated membranes (MAM)...
Enregistré dans:
| Publié dans: | Exp Ther Med |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
D.A. Spandidos
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8237397/ https://ncbi.nlm.nih.gov/pubmed/34194548 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2021.10302 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|